Hemangiosarcoma: Clinical Trials

13 trials for Hemangiosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 terminated, 1 unknown. 13 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 10, Terminated 2, Unknown 1
Phase 21Terminated 1

Follow Hemangiosarcoma: new trials by email Literature Review of Hemangiosarcoma trials Research Report on Hemangiosarcoma

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma
TRC105, Votrient - Advanced Angiosarcoma
Phase 3CompletedTracon Pharmaceuticals Inc.1282017-02-132020-05-12
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma
Phase 2 / Phase 3TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC1332011-05-012014-08-08
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
doxorubicin hydrochloride, clinical observation, therapeutic conventional surgery - Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma
Phase 3CompletedChildren's Oncology Group5882007-02-052022-04-28
Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma
radiotherapy - Sarcoma
Phase 3CompletedSheffield Teaching Hospitals NHS Foundation Trust2162006-03-012021-03-18
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
doxorubicin hydrochloride, ifosfamide, adjuvant therapy - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma
Phase 3UnknownEuropean Paediatric Soft Tissue Sarcoma Study Group2502006-03-012013-08-12
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
conventional surgery, radiation therapy - Sarcoma
Phase 3CompletedAlliance for Clinical Trials in Oncology3702004-08-012016-07-06
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
pegfilgrastim, doxorubicin hydrochloride, ifosfamide - Sarcoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC4552003-04-012014-10-27
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
doxorubicin hydrochloride, ifosfamide - Sarcoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC7801998-01-012012-01-20
Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
doxorubicin hydrochloride, etoposide, ifosfamide - Sarcoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC3401997-07-012013-09-17
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
filgrastim, doxorubicin hydrochloride, ifosfamide - Endometrial Cancer, Kidney Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC3401996-04-012012-07-11
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
filgrastim, doxorubicin hydrochloride, ifosfamide - Endometrial Cancer, Kidney Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC3501995-02-012014-08-08
Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
dactinomycin, carboplatin, cyclophosphamide - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma
Phase 3CompletedSociete Internationale d'Oncologie Pediatrique4001995-01-012013-12-04

Narrower conditions

Fibrosarcoma (12)  ·  Sarcoma (12)  ·  Liposarcoma (11)  ·  Histiocytoma, Malignant Fibrous (9)  ·  Leiomyosarcoma (9)  ·  Neurofibrosarcoma (9)  ·  Sarcoma, Synovial (9)  ·  Hemangiopericytoma, Malignant (8)  ·  Malignant mesenchymal tumor (6)  ·  Sarcoma, Alveolar Soft Part (5)  ·  Rhabdomyosarcoma (4)  ·  Chondrosarcoma, Extraskeletal Myxoid (3)  ·  Sarcoma, Endometrial Stromal (3)  ·  Chondrosarcoma (2)

Broader conditions

Neoplasms by Histologic Type (13)  ·  Neoplasms, Connective and Soft Tissue (13)  ·  Neoplasms, Vascular Tissue (13)  ·  Neoplasms (12)  ·  Neoplasms, Connective Tissue (12)  ·  Neoplasms, Fibrous Tissue (12)  ·  Neoplasms, Adipose Tissue (11)  ·  Neoplasms, Nerve Tissue (11)  ·  Nervous System Diseases (10)  ·  Nervous System Neoplasms (10)  ·  Peripheral Nervous System Neoplasms (10)  ·  Histiocytoma (9)  ·  Neoplasms, Muscle Tissue (9)  ·  Nerve Sheath Neoplasms (9)  ·  Neurofibroma (9)

Interventions

Doxorubicin (8)  ·  Ifosfamide (8)  ·  Radiotherapy (6)  ·  Chemotherapy, Adjuvant (3)  ·  Etoposide (2)  ·  Filgrastim (2)  ·  Neoadjuvant Therapy (2)  ·  Brachytherapy (1)  ·  Carboplatin (1)  ·  Combined Modality Therapy (1)  ·  Cyclophosphamide (1)  ·  Cyproheptadine (1)  ·  Dactinomycin (1)  ·  Diathermy (1)  ·  Epirubicin (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (6)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Children's Oncology Group (1)  ·  European Paediatric Soft Tissue Sarcoma Study Group (1)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)  ·  Societe Internationale d'Oncologie Pediatrique (1)  ·  Tracon Pharmaceuticals Inc. (1)  ·  University of South Florida (1)

Countries

United Kingdom (8)  ·  France (6)  ·  Germany (6)  ·  Spain (6)  ·  Austria (5)  ·  Belgium (5)  ·  Denmark (5)  ·  United States (5)  ·  Canada (4)  ·  Netherlands (4)  ·  Slovakia (4)  ·  Switzerland (4)  ·  Poland (3)  ·  Hungary (2)  ·  Italy (2)

Top investigators

A.N. Van Geel, MD (1)  ·  Andrea Ferrari, MD (1)  ·  Bernadette Brennan, MD (1)  ·  Charles Theuer, MD (1)  ·  Ian R. Judson, MA, MD, FRCP (1)  ·  James E. Butrynski, MD (1)  ·  Jeffrey P. Krischer, PhD (1)  ·  Joern Treuner, MD (1)  ·  Laurence H. Baker, DO, FACOI (1)  ·  M. C. G. Stevens, MD (1)  ·  Martin Robinson, MD (1)  ·  Max Van Noesel, MD, PhD (1)  ·  Modesto Carli, MD (1)  ·  Nguyen Binh Bui, MD (1)  ·  Paul C. Lorigan, MD (1)

Results publications

PMID 17634494, PMID 20434400, PMID 22665534, PMID 22954508, PMID 24618336, PMID 24747207, PMID 28391003, PMID 29450452, PMID 30357394, PMID 30954717, PMID 31786124, PMID 33548339, PMID 34623899, PMID 34666214, PMID 35357396, PMID 36566574, PMID 38757485, PMID 39122389, PMID 41386267, PMID 42035475

NIH funding

2009 (1), U10CA081920 (1), U10CA098543 (1)